Invexans S.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was USD 3,804.27 million compared to USD 1,832.99 million a year ago. Net income was USD 134.98 million compared to USD 15.51 million a year ago.

Basic earnings per share from continuing operations was USD 0.0027 compared to USD 0.0004 a year ago. Diluted earnings per share from continuing operations was USD 0.0027 compared to USD 0.0004 a year ago.